Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol.
about
A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretionFrom evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transportHepatic farnesoid X-receptor isoforms α2 and α4 differentially modulate bile salt and lipoprotein metabolism in miceA new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport.Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise trainingLiver X receptors at the intersection of lipid metabolism and atherogenesisRole of the intestinal bile acid transporters in bile acid and drug dispositionA reappraisal of the mechanism by which plant sterols promote neutral sterol loss in miceLiver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in miceCoordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 DiabetesAcute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice.Biliary sterol secretion is not required for macrophage reverse cholesterol transportCooperative transcriptional activation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 genes by nuclear receptors including Liver-X-Receptor.C57Bl/6 N mice on a western diet display reduced intestinal and hepatic cholesterol levels despite a plasma hypercholesterolemiaCell cholesterol homeostasis: mediation by active cholesterolPCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells.Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.Relative roles of ABCG5/ABCG8 in liver and intestine.The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination.Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice.ABCG5/G8 deficiency in mice reduces dietary triacylglycerol and cholesterol transport into the lymph.Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans.The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance.Future therapeutic directions in reverse cholesterol transport.Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies.Trust your gut: galvanizing nutritional interest in intestinal cholesterol metabolism for protection against cardiovascular diseasesThe Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A.Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer proteinIntestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice.Biliary and nonbiliary contributions to reverse cholesterol transport.Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol effluxNovel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism.Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression.Insig proteins mediate feedback inhibition of cholesterol synthesis in the intestine.Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol Loss.Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in miceDifferential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice.Reverse cholesterol transport: from classical view to new insights.
P2860
Q26865600-635C1033-2D96-447B-8D7E-A48560D04C0DQ26997647-61B68E08-729D-4AD3-92EA-8C7E39ACEDB3Q27320737-C95C47DA-7BCA-45FE-806C-856FF51A77FAQ27693251-E3BE0A2C-1135-4E46-B5F7-31F91ED308D7Q28073180-50BCB73E-B953-4F51-B470-B3C22A62B302Q28082452-E190FC62-2A08-447C-97E9-115B50C44AC5Q28299162-CB1F7016-AE69-4675-B245-E0DBC030959AQ28743016-17136820-A2B2-426F-B455-CCC290B94043Q30426995-A1564649-9AA4-44A4-BAD9-A4F64C5107CFQ33608251-729AF85E-C57C-4AA3-BC7A-2CD1F46A1EE5Q33717139-3872B7D0-15A0-4CE1-973F-E57F4B249EE6Q33894773-A9D41B33-C003-4A7D-9666-74699136D57EQ34035681-A5BC27EE-31CC-4342-A16B-A840C36EA437Q34049505-471FD272-F0F3-4769-9838-2877928A8DF9Q34186425-B9C69FB3-7C18-4F1E-8F98-BF65C73D0205Q34258914-BC5E29EE-0FA5-41B2-9B5E-F6EA4B836348Q34433146-454F13F9-BEEA-4F1E-9490-E98B9ED5BFA9Q34531158-8C28936F-950D-4FD1-B61E-931814BBD0CCQ35014254-2981BE43-BD85-4A0B-AB52-EEEE6EDCAD62Q35217035-ECDE7893-19E4-4823-AD01-9D9E184F9C0EQ35747737-9DFE7A26-8AD2-4497-B1B9-B5A56A168696Q35815267-07C08C6D-AA35-4D0D-8536-3761C5CE7925Q35832477-D2BB2DBF-223B-47C9-9C19-ED56CB73E479Q35850568-018C34C5-B70E-4749-8367-90549DFDBD57Q35860010-704E8178-60CB-4BCA-B277-334C5E0994C0Q36007212-D37D4080-D97F-40A8-ACEE-62462224261FQ36607669-4715BFC7-3DE8-4E20-94E0-2A7827265BF7Q36610558-06E9C3C7-91B2-46A4-8EB4-A2FBA4FB4FA1Q36683297-B57C2539-70CB-414E-BADB-7A77C3BEBA6DQ36747243-BAE6708E-A0F7-4FAC-895E-657910377EE6Q36822555-A0C87E18-340D-423E-8A35-BEAE9027E1FAQ37013347-0D2BA1D7-C4A2-4F82-A39E-91FB9C32C82EQ37033119-BCF3DE5F-4FA0-4FA9-AF60-251E5D0882ADQ37103346-AF565989-A9E4-4FB9-80C0-8C6E3058833AQ37368738-D778246A-E40D-448B-A6EF-9B6C7142A57EQ37511728-386E223A-6B4C-4667-84DA-0788BE3F8AC0Q37573558-6AC8F8D5-860F-47B9-9FDC-890EE6999FD8Q37662885-8B2435C2-D618-4010-AFD5-8EBE0FDC3A0FQ37716347-4478F6FE-03A6-41C5-BE99-0303CDE47FCBQ37820949-ECDA5E7E-2014-433B-83CE-F7587373CCE5
P2860
Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activation of the liver X rece ...... cretion of plasma cholesterol.
@en
Activation of the liver X rece ...... cretion of plasma cholesterol.
@nl
type
label
Activation of the liver X rece ...... cretion of plasma cholesterol.
@en
Activation of the liver X rece ...... cretion of plasma cholesterol.
@nl
prefLabel
Activation of the liver X rece ...... cretion of plasma cholesterol.
@en
Activation of the liver X rece ...... cretion of plasma cholesterol.
@nl
P2093
P2860
P356
P1476
Activation of the liver X rece ...... cretion of plasma cholesterol.
@en
P2093
Albert K Groen
Carlos L J Vrins
Folkert Kuipers
Hester van Meer
Jelske N van der Veen
Klaas Bijsterveld
Rick Havinga
Theo H van Dijk
Uwe J F Tietge
P2860
P304
19211-19219
P356
10.1074/JBC.M109.014860
P407
P577
2009-05-05T00:00:00Z